Scientists from Northwestern University announced a major breakthrough in understanding how the brain clears amyloid plaques in Alzheimer’s disease.
The study revealed that activating microglia — the brain’s immune cells — can significantly enhance the removal of harmful protein deposits, opening new therapeutic possibilities not only for Alzheimer’s disease but also for other neurodegenerative disorders such as Parkinson’s disease and ALS. (Source)
The analysis of 25 post-mortem brain samples, including 13 patients who had received anti-amyloid beta vaccines, showed that 7 of them demonstrated effective plaque clearance.
This finding highlights the potential of microglia activation in combating pathological brain changes.
These results could lay the foundation for the development of new treatments aimed at stimulating microglial activity, offering new hope for patients with neurodegenerative diseases.
